Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
0
Bearish filings
103
Named actors
20
Disclosed $ (bull / bear)
— / $74.7M + 18 of unknown size
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-08-18 | Director OLUKOTUN ADEOYE Y | sold | $174K | SEC ↗ |
| 2026-08-18 | Director PERRY MICHAEL S | sold | $1.0M | SEC ↗ |
| 2026-08-18 | Director (via Merrill Lynch) Michael Perry | filed notice to sell | $1.0M | SEC ↗ |
| 2026-08-18 | Director (via Merrill Lynch) Adeoye Olukotun | filed notice to sell | $174K | SEC ↗ |
| 2026-05-19 | Officer (via Merrill Lynch) James Hamilton | filed notice to sell | $750K | SEC ↗ |
78 more disclosures in the window — the full record, scoring, and track-record evidence are for members.
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-05-19 | Officer (via Merrill Lynch) Hongbo Lu | filed notice to sell | $228K | SEC ↗ |
| 2026-05-19 | Officer (via Merrill Lynch) Daniel Apel | filed notice to sell | $934K | SEC ↗ |
| 2026-05-12 | Director Lu Hongbo | sold | $228K | SEC ↗ |
| 2026-05-07 | Board Member Adeoye Olukotun | adopted a selling plan | — | SEC ↗ |
| 2026-05-07 | Board Member Victoria Vakiener | adopted a selling plan | — | SEC ↗ |
| 2026-05-07 | Chief Financial Officer Daniel Apel | adopted a selling plan | — | SEC ↗ |
| 2026-05-07 | Board Member William Waddill | adopted a selling plan | — | SEC ↗ |
| 2026-05-07 | Board Member Hongbo Lu | adopted a selling plan | — | SEC ↗ |
| 2026-04-23 | Chief Medical Officer Hamilton James C | sold | $750K | SEC ↗ |
| 2026-04-22 | Chief Financial Officer Apel Daniel Joseph | sold | $628K | SEC ↗ |
| 2026-04-22 | Chief Financial Officer Apel Daniel Joseph | sold | $82K | SEC ↗ |
| 2026-04-22 | Chief Financial Officer Apel Daniel Joseph | sold | $225K | SEC ↗ |
| 2026-03-05 | Officer (via Merrill Lynch) James Hamilton | filed notice to sell | $642K | SEC ↗ |
| 2026-03-05 | Chief Medical Officer Hamilton James C | sold | $642K | SEC ↗ |
| 2026-02-05 | President and Chief Executive Officer Christopher Anzalone | adopted a selling plan | — | SEC ↗ |
| 2026-02-05 | Chief Medical Officer, Head of R&D James Hamilton | adopted a selling plan | — | SEC ↗ |
| 2026-01-06 | COO O'Brien Patrick | gifted | — | SEC ↗ |
| 2026-01-06 | COO O'Brien Patrick | gifted | — | SEC ↗ |
| 2026-01-05 | COO O'Brien Patrick | sold | $3K | SEC ↗ |
| 2026-01-05 | COO O'Brien Patrick | sold | $369K | SEC ↗ |